| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |